Menu
Request a demo

Our products

An agile launch execution platform, with full visibility across countries and functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across countries.
A capability management platform that unifies capabilities, resources, and assessment.

Our expertise

Launch Readiness

Market Access

Tender Management

Featured Post

3 Pharma Trends for 2024: All about market access

  • Andre Moa
  • 12 Dec 2023
  • 19 minute read

Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.

Read more

Latest posts

What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective

The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations

Read more

How COVID-19 has accelerated digital transformation in pharma

The COVID-19 pandemic is a wake-up call for pharma to embed digital transformation at every level of its operations

Read more

Product launches: making the most of your one shot

Pharma companies need a launch execution platform that makes launch excellence the norm and streamlines efforts to save time for everyone involved in product launches.

Read more

Rethinking Launch Readiness in 2021: The New Normal in the Shadow of COVID

COVID-19 has intensified launch challenges facing new drugs. R&D pipelines and regulatory approvals continue to deliver innovation and commercial promise.

Read more

5 Pharma Trends for 2021: Disruption and Transformation in the COVID Era

The impact of COVID-19 threads through our 5 pharma trends for 2021, whether driving vaccine R&D or political change, hampering market access or accelerating digital transformation.

Read more

2020 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations

Despite the threat of pandemic disruption, US and EU drug approvals for 2020 are in good health, with breakthrough innovation much in evidence.

Read more

How the coronavirus crisis could affect your new drug launch

The coronavirus is forcing pharma to think creatively about remote working in a constrained environment. Digital technology will be crucial in softening the pandemic’s multiple impacts on drug launches.

Read more

From Volume to Value: Strategising launch readiness in 2020

The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.

Read more

5 Pharma Trends for 2020: Counting the value and cost of innovation

The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.

Read more

2019 New Drug Approvals And Updates: The Year In Review

US and EU drug approvals for 2019 may be lagging last year’s peaks, but innovation and blockbuster potential are far from exhausted.

Read more

How digital transformation can streamline your new pharma product launch

Digital transformation has brought benefits but also challenges for pharma launches. With the right software, launch teams can ensure digital works to their advantage.

Read more

How to stay on top of your global market access challenges

The right software will help you turn an array of market access challenges for new medicines into competitive differentiation that drives launch success.

Read more

Recent Posts

Most Popular Posts

Categories

Get our latest
posts in your inbox

TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.